Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein-3

Endocrinology

Volumn 138, Issue 9, 1997, Pages 3912-3917

  Bang, Peter ^a   Fielder, Paul J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM SULFATE; MACROGOL; PLASMIN; PLASMINOGEN; PROTEINASE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; ENZYME ACTIVITY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; ION EXCHANGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; RODENT;

EID: 0030755476     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.9.5371     Document Type: Article

References (27)

1. Bang P, Hall K 1992 Insulin-like growth factors as endocrine and paracrine hormones. In: Schofield PN (ed) The Insulin-Like Growth Factors: Structure and Biological Functions. Oxford University Press, New York, pp 151-168
2. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins. Endocr Rev 16:3-34
3. Baxter RC, Martin JL, Beniac VA 1989 High molecular weight insulin-like growth factor complex; purification and properties of the acid-labile subunit from human serum. J Biol Chem 264:11843-11848
4. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: Effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab 71:806-816
5. Hossenlopp P, Sergovia B, Lassarre C, Roghani M, Bredon M, Binoux M 1990 Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J Clin Endocrinol Metab 71:797-805
6. Fielder PJ, Thordarson G, Talamantes F, Rosenfeld RG 1990 Characterization of insulin-like growth factor binding proteins (IGFBFs) during gestation in mice: effects of hypophysectomy and an IGFBP-specific serum protease activity. Endocrinology 127:2270-2280
7. Laserre C, Binoux M 1994 Insulin-like Growth Factor Binding Protein-3 is functionally altered in pregnancy plasma. Endocrinology 134:1254-1262
8. Blat C, Villaudy J, Binoux M 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93:2226-2229
9. Hasagawa Y, Takada M, Hasagawa T, Tsuchiya Y 1994 Clinical utility of newly developed free insulin-like growth factor-I by IRMA. Clin Pediatr Endocrinol 3[Suppl 5]:160-161 (Abstract)
10. Binoux M, Lalou C, Lassarre C, Blat C, Hossenloop P 1994 Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): A physiological mechanism in the regulation of IGF bioavailability. In: LeRoith D, Raizada MK (eds) Current Directions in Insulin-Like Growth Factor Research. Plenum Press, New York, pp 293-300
11. Davenport ML, Pucilowska JB, Clemmons DR, Lundblad R, Spencer JS, Underwood LE 1992 Tissue-specific expression of insulin-like growth factor binding protein-3 protease activity during rat pregnancy. Endocrinology 130:2505-2512
12. Suikkari A-M, Baxter RC 1992 Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum. J Clin Endocrinol Metab 74:177-183
13. Lassarre C, Binoux M 1994 Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology 134:1254-1262
14. Giudice, LC, Irwin JC, Dsupin BA, de las Fuentes L, Jin IH, Vu TH, Huffman AR 1994 Insulin-like growth factors (IGFs), IGF binding proteins (IGFBPs) and IGFBP protease in human uterine endometrium: their potential relevance to endometrial cyclic function and maternal-embryonic interactions. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-Like Growth Factors and Their Regulatory Proteins. Excerpta Medica, Amsterdam, The Netherlands, pp 351-361
15. Bang P, Stangenberg M, Westgren M, Rosenfeld RG 1994 Decreased ternary complex formation and predominance of a 29 kDa IGFBP-3 fragment in human fetal serum. Growth Regul 4:68-76
16. Lewitt MS, Scott FP, Clarke NM, Baxter RC 1995 Developmental regulation of circulating insulin-like growth factor binding proteins in normal pregnancies and in pre-eclampsia. Prog Growth Factor Res 6:475-480
17. Davies SC, Holly JM, Coulson VJ, Catterhill AM, Abdulla AF, Whittaker DG, Chard T, Wass JA 1991 The presence of cation-dependent proteases for insulin-like growth factor binding proteins does not alter the size distribution of insulin-like growth factors in pregnancy. Clin Endocrinol (Oxf) 34:501-506
18. Bang P, Brismar K, Rosenfeld RG 1994 Increased proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29 kDa glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J Clin Endocrinol Metab 78:1119-1127
19. Fowlkes JL, Suzuki K, Nagase H, Thrailkill KM 1994 Proteolysis of insulinlike growth factor binding protein-3 during rat pregnancy: A role for matrix metalloproteinases. Endocrinology 135:2810-2813
20. Lamson G, Giudice LC, Rosenfeld RG 1991 A simple assay for proteolysis of IGFBP-3. J Clin Endocrinol Metab 72:1391-1393
21. Fielder PJ, Rosenfeld RG, Graves HCB, Grandbois K, Maack CA, Sawamura S, Sommer A, Cohen P 1995 Biochemical analysis of prostate specific antigen (PSA)-proteolyzed insulin-like growth factor binding protein-3. Growth Regul 1:164-172
22. Campbell PG, Novak JF, Yanosick TB, McMaster JH 1992 Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology 130:1401-1412
23. Clemmons DR, Nam TJ, Busby WH, Parker A 1994 Modification of IGF action by insulin-like growth factor binding protein-5. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds). The Insulin-Like Growth Factors and Their Regulatory Proteins. Excerpta Medica, Amsterdam, The Netherlands, pp 183-191
24. Conover CA 1995 Insulin-like growth factor binding protein proteolysis in bone cell models. Prog Growth Factor Res 6:301-309
25. Campbell PG, Novak JF, Wines K, Walton PE 1993 Localization of plasmin activity on osteosarcoma cells: cell surface proteolysis of insulin-like growth factor binding proteins. Growth Regulation 3:95-98
26. Lalou C, Silve C, Rosato R, Segovia B, Binoux M 1994 Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology 135:2318-2326
27. Sprengers ED, Kluft C 1987 Plasminogen activator inhibitors. Blood 69:381-387